Skip to main content
Gynecologic Cancer Breast Cancer

Breast Cancer

10-07-2024 Breast Cancer News

Acupuncture reduces side effects of breast cancer treatment

Acupuncture could help ease hot flashes and other endocrine symptoms in women undergoing endocrine therapy for breast cancer.

Editor's Choice

Axillary management: less can be more

Open Access Breast Cancer Review

Management of the axilla in patients with breast cancer has evolved considerably over the past three decades, from routine clearance to complete omission in select patients. Explore the evidence that has shaped these practice changes.

Update on CDK4/6 inhibitors for breast cancer

A comprehensive overview of the latest efficacy and toxicity data for the CDK4/6 inhibitors available for the treatment of early and metastatic HR-positive, HER2-negative breast cancer.

No reduction in breast cancer recurrence with aspirin

30-04-2024 Breast Cancer News

The Alliance A011502 trial has ruled out the adjuvant use of aspirin for the prevention of breast cancer recurrence in people with high-risk nonmetastatic disease.

ADCs in cancer: key data for currently approved agents

Open Access Cancer Therapy Review

Delve into the efficacy and safety data for the antibody–drug conjugates currently approved by the US FDA across tumor types such as hematologic, genitourinary, and gynecologic cancers.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare

Case Studies

A rare, late side effect of radiotherapy

Open Access Breast Cancer Case Study

A woman developed sudden painless ecchymosis (bruising) of her breast, which was thought to be related to the radiotherapy she received for early-stage breast cancer a year and a half earlier.

Breast metastases in a male patient with nasopharyngeal carcinoma

Open Access Nasopharyngeal Cancer Case Study

Nasopharyngeal carcinoma is known for its high potential to metastasize, but breast metastasis is rare. The authors describe the first case of synchronous breast metastases in a male patient.

HER2-positive mucoepidermoid carcinoma of the breast

Open Access Breast Cancer Case Study

Mucoepidermoid carcinoma of the breast is a rare type of salivary gland-like tumor that generally displays a triple-negative phenotype. This case is the first to demonstrate HER2 gene amplification.

Case-Based Insights: Oncology and Hematology (Link opens in a new window)


Refresh your knowledge in Oncology and Hematology: 

  • 45 clinical cases across different topics with relevant clinical images
  • Written by renowned experts 
  • Knowledge-check questions with answers
Try the first set of cases now

Current Reviews

The effect of BMI on survival outcome of breast cancer patients: a systematic review and meta-analysis

Breast Cancer REVIEW ARTICLE

Breast cancer remains the most prevalent cancer type and the primary cause of cancer-related deaths among women worldwide [ 1 ]. The latest global cancer statistics from 2022 reveal a shift where female breast cancer has surpassed lung cancer …

Mechanisms of stress-attributed breast cancer incidence and progression

Breast Cancer Review Paper

Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer deaths in women, with psychosocial stress commonly cited by patients as one of its causes. While there is conflicting epidemiological evidence investigating …

Neuroendocrine neoplasms of the breast: a review of literature

Open Access Breast Cancer REVIEW AND PERSPECTIVES

Primary neuroendocrine neoplasms (NENs) of the breast are characterized by neuroendocrine architectural and cytological features, which must be supported by immunohistochemical positivity for neuroendocrine markers (such as Chromogranin and …

The association between infectious agents and breast cancer: a review of the epidemiologic evidence

Studies have successfully demonstrated causal linkages between several viruses and the development of human cancers, which have enabled antiviral modes of prevention. Following the discovery of a causal link between human papilloma virus (HPV) and …

Webinar | 16-05-2023 | 17:30 (CEST)

Keynote webinar | Spotlight on cardio-oncology

An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.

Prof. Rudolf de Boer
Prof. Lorenz Lehmann
Dr. Teresa Lopéz Fernández

CME & eLearning

eLearning | Interviews | Cases (Link opens in a new window)

0.75 AMA PRA Category 1 Credit(s)

Knowledge center focusing on improving the individualized management of HR+/HER2- early breast cancer.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME

Further Reading

Breast density effect on the sensitivity of digital screening mammography in a UK cohort

Open Access Mammography Breast

Breast cancer is one of the most common forms of cancer and early-stage diagnosis leads to better survival [ 1 ]. Population screening programmes aim to detect cancer early and reduce mortality. The UK National Health Service Breast Screening …

Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer

Open Access Breast Cancer Original Article

Breast cancer is one of the most common malignant diseases worldwide and was the most common cancer among women in 2020 [ 1 ]. Among Japanese women, breast cancer is the most frequently diagnosed cancer, with 97,142 cases and 14,650 deaths reported …

Radiation exposure and screening yield by digital breast tomosynthesis compared to mammography: results of the TOSYMA Trial breast density related 

Open Access Mammography Breast

Breast cancer is the leading cause of cancer morbidity and mortality in women worldwide [ 1 ]. Mammography screening is an effective tool for early breast cancer detection and has been proven to reduce the number of deaths by breast cancer [ 2 , 3 …